![Hartmut Juhl](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Hartmut Juhl
Director Ejecutivo en Indivumed GmbH .
Perfil
Hartmut Juhl is the founder.
He founded Indivumed GmbH in 2002 and currently holds the title of Chief Executive Officer.
In addition to his founding position, Dr. Juhl also worked as an Associate Professor at Georgetown University.
He obtained a doctorate degree from the University of Hamburg.
Cargos activos de Hartmut Juhl
Empresas | Cargo | Inicio |
---|---|---|
Indivumed GmbH
![]() Indivumed GmbH Data Processing ServicesTechnology Services Indivumed GmbH engages in the research and development of medical treatment for cancer patients. The firm develops an integrated analytical platform, which links sample sets from cancer patients such as tissue types, serum, plasma, and urine with a web-accessible database. It offers treatment for the people suffering from GI-tract such as colorectal, gastric, pancreatic, breast, and lung cancer. The company was founded by Hartmut Juhl, Carsten Zornig and Peter Layer in April 2002 and is headquartered in Hamburg, Germany. | Director Ejecutivo | 01/04/2002 |
Antiguos cargos conocidos de Hartmut Juhl.
Empresas | Cargo | Fin |
---|---|---|
Georgetown University | Corporate Officer/Principal | - |
Formación de Hartmut Juhl.
University of Hamburg | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 1 |
---|---|
Indivumed GmbH
![]() Indivumed GmbH Data Processing ServicesTechnology Services Indivumed GmbH engages in the research and development of medical treatment for cancer patients. The firm develops an integrated analytical platform, which links sample sets from cancer patients such as tissue types, serum, plasma, and urine with a web-accessible database. It offers treatment for the people suffering from GI-tract such as colorectal, gastric, pancreatic, breast, and lung cancer. The company was founded by Hartmut Juhl, Carsten Zornig and Peter Layer in April 2002 and is headquartered in Hamburg, Germany. | Technology Services |
- Bolsa de valores
- Insiders
- Hartmut Juhl